Venture Capital

As oncologists warn of supplement risks, one company founded by a doctor and caregiver aims to provide a safer, transparent path for cancer survivors.

A breakthrough in mycelium-based infection detection has prompted Mushrooms Inc. to halt a merger, betting its future on its own innovative biotech platform.

GoNetspeed is investing $13.6M to bring multi-gigabit fiber internet to South River, sparking new competition and future-proofing the NJ borough.

Doctronic's AI can now legally renew prescriptions. Its massive new funding signals a new era in healthcare, but experts are raising serious safety concerns.

A Vancouver firm's revolutionary tech, backed by government funds, aims to decarbonize metal recovery and secure North America's platinum supply chain.

The scientist behind PARP inhibitors is backing a new approach. Dr. Alan Ashworth's appointment at Leapfrog Bio signals a major push in precision oncology.

Attending a science workshop and a power conference, the OTC-listed firm signals its push to bridge the gap between lab theory and grid reality.

A new joint venture from ZJD and Branded Capital Solutions aims to provide tailored capital solutions without demanding majority buyouts from franchise owners.

With a new national headquarters in Mount Laurel, GalenusCare aims to combat the deadly risks of polypharmacy for elderly and hospice patients nationwide.

The Saint Paul-based installer was named a 2026 Regional Installer of the Year, highlighting its excellence in the Midwest's evolving clean energy market.

This Michigan startup made Fast Company's Most Innovative list by using AI to turn landfill-bound wood into renewable energy and big savings for contractors.

New York University secures the #1 spot for both undergrad and grad programs as new data reveals high starting salaries for game design graduates.

A top European business conference sold out six months early. It's a clear signal leaders are prioritizing human skills in a world dominated by AI.

With AI automating code, a new startup says the real challenge is planning. Backed by Menlo Ventures, BrainGrid is building the tools for non-coders.

A new $1.35M program seeks to validate diagnostic tests for Long COVID, paving the way for targeted treatments and offering hope to millions.

Artis BioSolutions is opening a new synthetic DNA facility in Boston, aiming to reduce supply chain risks and accelerate next-gen medicine development.

A US-Japan biotech firm secures major funding to advance a first-in-class drug, offering new hope for millions with inherited blood disorders.

A new platform from cybersecurity veteran John Watters aims to revolutionize third-party risk with "compromise intelligence," detecting attacks on vendors early.

Modalic's autonomous swarm software gets 'awardable' status, signaling a major shift in how the Department of War rapidly acquires advanced AI.

As the Pentagon accelerates its AI push, Striveworks lands key funding to expand its AIOps platform, aiming to deliver fast, trusted AI to the front lines.